Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
Research output: Contribution to journal › Article › peer-review
7Citations
(Scopus)
173Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial'. Together they form a unique fingerprint.